About

Built where medicinal chemistry meets capital markets.

Avenbuan Bio Intelligence is a Dublin-headquartered, AI-augmented competitive-intelligence firm serving pharma and biotech leaders across Ireland, the EU, the UK, and the United States.

Mission

To raise the analytic floor of strategic decisions in the life sciences.

Most pharma intelligence outputs are written either by management consultants who don’t read mechanism-of-action data, or by scientists who don’t price franchise economics. Avenbuan Bio Intelligence sits at the intersection.

We pair doctorate-level scientific literacy with the rigour of a sell-side analyst and the velocity of an AI-augmented research stack. Every figure we publish is traceable to a primary source — SEC filings, FDA / EMA / NICE decisions, IDA Ireland, NEJM, The Lancet. Nothing makes it into an Avenbuan deliverable without surviving our four-stage verification gate.

Endrice Avenbuan — Founder & Principal, Avenbuan Bio Intelligence
Founder

Endrice Avenbuan

Founder & Principal. Bachelor’s (Moderatorship) in Medicinal Chemistry at Trinity College Dublin (Expected First Class Honours, 2026). Healthcare & pharma equity research at Trinity Student Managed Fund (€500,000 AUM). Internships across BlackRock, Fidelity International, and Citigroup.

Education

Trinity College Dublin — B.A. (Mod.) Medicinal Chemistry. Third Year: First Class Honours (71%). Relevant coursework: Statistics, Data Analysis, Drug Design, Scientific Report Writing, Research Project. Holy Family Community School, Rathcoole — Irish Leaving Cert 520/625 (84th percentile).

Experience

Trinity Student Managed Fund — Junior Analyst, Healthcare & Pharmaceuticals (Sept 2023 – Mar 2024). Led a four-person team preparing an ESG-criteria investment pitch book for the UK & Ireland Temasek Impact Investing Challenge (Imperial College London Investment Society). DCF, comparables, precedent-transactions, financial-statement, and ESG analysis on ICU Medical Inc.

BlackRock — Black Heritage Insight Programme intern (London, Sept 2023). Portfolio simulations on Aladdin across equity, fixed income, and multi-asset portfolios.

Fidelity International — Summer Talent Academy intern (London, Jul 2023). 2nd in the team challenge for a multi-asset product targeting Gen Z investors.

The University of Manchester — Wellcome Trust Biomedical Vacation Research Scholar (Jun–Jul 2022). Six-week biomedical research project on osteoarthritis under Prof. Tony Day.

Citigroup (Citi) — Spring Intern (Dublin, April 2022). Selected from 5,000+ applicants. Built and presented an IPO pitch in a simulated deal environment.

Skills & certifications

Microsoft PowerPoint, Excel, Word Bloomberg Terminal Python Bloomberg Market Concepts ECDL Essentials English (native) German (intermediate) Irish (intermediate)

View LinkedIn profile →

Principles

Six commitments that govern every engagement.

1. Primary sources or silence

If we can’t trace it to an SEC filing, regulator, or peer-reviewed journal, we don’t publish it.

2. No AI hallucinations

AI accelerates extraction and synthesis. Human verification gates every claim. There are no exceptions.

3. Fixed scope, fixed fee

Scope, timeline, fee, and deliverable format agreed in one page before kickoff. No hourly-billing surprises.

4. Decision-grade language

Memos are written for principals. Short paragraphs, decisive verbs, explicit recommendations.

5. Conflict transparency

Conflict screen before every engagement. We disclose past and current work that touches the question.

6. Independence

No retained-search side practice, no kickbacks from licensors, no advisory boards we haven’t disclosed.

Trust & compliance

Operating standards.

Data & confidentiality

NDA accepted as standard. Client documents stored in encrypted, access-controlled workspaces. No client data is used to train or fine-tune AI models, ever.

Privacy & GDPR

Avenbuan operates from the European Union and complies with the General Data Protection Regulation (Regulation (EU) 2016/679). A data-processing addendum is available on request.

Independence

We do not accept payment from companies whose assets we are evaluating. Conflict screens are conducted on every engagement, before scoping begins.

Not advice

Avenbuan Bio Intelligence is an independent advisory firm. Our deliverables do not constitute investment, medical, legal, or tax advice. All materials are for the use of named clients and their professional advisers.

Like what you see?

Send the question. We’ll come back within one working day with scope, timeline, and a fixed fee.

Contact us →